Retina is a Marker for Cerebrovascular Heath
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT04753970
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 1/2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04753970
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04753970. Randomized; no masking; primary purpose prevention. Start 2021-02-09 (actual); primary completion 2030-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Retina is a Marker for Cerebrovascular Heath
- Condition
- Cerebral Small Vessel Diseases
- Condition
- Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
- Condition
- Cerebral Microbleeding
- Condition
- Sporadic White Matter Disease
- Intervention (Drug)
- Cilostazol
- Lead sponsor
- Mayo Clinic
Record details
- Record id
cardio:ct-nct04753970- Content hash
3a8c755a1511caf5ff4f6caf6b3f899e11e0fb7fe1ead00c975d47812c18524b